| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.024 | 0.4 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.042 | 0.4 |